Junten Bio

Developer of regenerative medicine products for immune tolerance induction

placeChiyoda City, Tokyo, Japan calendar_todayFounded 2018 language juntenbio.co.jp

Innovation

6 patent families (3 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace accelerating. Cited 340 times.

YearFilings
20193
20204
20213
20223
20231
20245
20256

Investor mix

2 investors on record.

Investor typeCountShare
Other / undisclosed2100%
Coming soon